Enterprise Together with KSC
Philophos, Inc.
Israel
Company Overview
Making low-cost and miniaturized OCT devices that provide the best diagnostic accuracy, especially in ophthalmology, to prevent blindness
Sectors
- Medical and Health IT
Project Summary
- Cost innovation and form-factor innovation of optical coherence tomography (OCT) devices
Business Model
- Revenue model Direct or indirect sales to hospitals and doctors (B2B or B2C) or B2G
- Key Customer Hospitals, distributors, governments
Major Performance
-
Sales
- USD 3.6K (2019)
- USD10K (up to now)
-
Investment
- USD 869K up to now from several VCs
-
Employees
- (2018) 2
- (2019) 7
- (2020 1H) 7
-
Patent
- 2 KR application
- 1 KR registration
- 2 PCT application
Overseas Expansion
Stage
Preparing for overseas expansion
Status
US, EU, Mideast, Thailand market research
Performance
Building a global network
Products / Services
1
2
- Target Country
- Israel
- Date of Establishment
- Mar. 02, 2018
-
- jung-ho.chung@ philophos.com jung-ho.chung@ philophos.com
-
- Website
- www.philophos.com www.philophos.com
-
- Location
- Daedeok-daero 556 beon-gil, Yuseong-gu, Daejeon
-
- CEO
- Jung-Ho Chung
-
- Founder’s Background
-
- Project leader @ LG Electronics (2008~2018)
- Postdoctoral Associate @ MIT (2005~2008)
- Master & Doctoral program @ Purdue University (1999~2005)